Some updates
368 Views01 Feb 2024 22:45
Syndicated
- Recently Avrobio (AVRO) announced a reverse merger with Tectonic Therapeutic, which was a bit unexpected.
- And disappointing. From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive insiders.
- But I have no idea how to value this. Net cash will be <$1/share post merger so I am closing this with a small loss at $1.25.
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)